Favorable outcomes of infants born after maternal COVID-19 during pregnancy Coronavirus Disease COVID Pregnancy aap_peds
By Tarun Sai LomteOct 30 2022Reviewed by Benedette Cuffari, M.Sc. In a recent Pediatrics journal study, researchers assessed the outcomes of children born to mothers infected during pregnancy with the severe acute respiratory syndrome coronavirus 2 .
Preterm neonates and newborns of those with peripartum SARS-CoV-2 infection or mothers without antibodies against SARS-CoV-2 were excluded. Data on demographics, comorbidities, disease severity, and trimester of infection were collected for all mothers. In addition, data on head circumference, GA, length, birth weight, clinical signs at birth, and hearing screening test results were collected for the neonates.
Related StoriesPeripartum SARS-CoV-2 infection was observed in 24 dyads. Most of the babies were vaginally delivered, while 28 required cesarean delivery. The researchers analyzed 32 placental biopsies for viral ribonucleic acid and noted only one positive sample. This SARS-CoV-2-positive biopsy specimen was from a study participant with mild illness eight weeks before delivery.
Growth parameters remained within normal limits for all infants during the one-year follow-up. Matched neonatal-maternal serum samples within two days of delivery were available for 100 dyads.